TNFRSF11A Antikörper (AA 28-202)
-
- Target Alle TNFRSF11A Antikörper anzeigen
- TNFRSF11A (Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A))
-
Bindungsspezifität
- AA 28-202
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFRSF11A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Tumor necrosis factor receptor superfamily member 11A protein (28-202AA)
- Isotyp
- IgG
- Top Product
- Discover our top product TNFRSF11A Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TNFRSF11A (Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A))
- Andere Bezeichnung
- TNFRSF11A (TNFRSF11A Produkte)
- Synonyme
- RANK antikoerper, RGD1563614 antikoerper, TNFRSF11A antikoerper, Ly109 antikoerper, ODFR antikoerper, OFE antikoerper, Rank antikoerper, TRANCE-R antikoerper, mRANK antikoerper, CD265 antikoerper, FEO antikoerper, LOH18CR1 antikoerper, OPTB7 antikoerper, OSTS antikoerper, PDB2 antikoerper, TRANCER antikoerper, TNF receptor superfamily member 11A antikoerper, TNF receptor superfamily member 11a antikoerper, tumor necrosis factor receptor superfamily, member 11a, NFKB activator antikoerper, Tnfrsf11a antikoerper, TNFRSF11A antikoerper
- Hintergrund
-
Background: Receptor for TNFSF11/RANKL/TRANCE/OPGL, essential for RANKL-mediated osteoclastogenesis. Involved in the regulation of interactions between T-cells and dendritic cells.
Aliases: CD 265 antibody, CD265 antibody, FEO antibody, LOH18CR1 antibody, Loss of heterozygosity 18 chromosomal region 1 antibody, mRANK antibody, ODFR antibody, OFE antibody, OPTB7 antibody, Osteoclast differentiation factor receptor antibody, OSTS antibody, Paget disease of bone 2 antibody, PDB 2 antibody, PDB2 antibody, RANK antibody, Receptor activator of NF KB antibody, Receptor activator of NF-KB antibody, receptor activator of nuclear factor kappa B antibody, TNF receptor superfamily member 11a antibody, TNFRSF11A antibody, TNR11_HUMAN antibody, TRANCER antibody, Tumor necrosis factor receptor superfamily member 11a NFKB activator antibody, Tumor necrosis factor receptor superfamily member 11a activator of NFKB antibody, Tumor necrosis factor receptor superfamily member 11A antibody
- UniProt
- Q9Y6Q6
- Pathways
- NF-kappaB Signalweg
-